Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
34,856,372
-
Share change
-
-2,944,946
-
Total reported value
-
$392,510,033
-
Put/Call ratio
-
160%
-
Price per share
-
$11.30
-
Number of holders
-
88
-
Value change
-
-$52,532,853
-
Number of buys
-
41
-
Number of sells
-
69
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2022
As of 30 Jun 2022,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,856,372 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., ARMISTICE CAPITAL, LLC, BlackRock Inc., NOMURA HOLDINGS INC, Cederberg Capital Ltd, VANGUARD GROUP INC, Artisan Partners Limited Partnership, GOLDMAN SACHS GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.